Compared with normal liver, the expression level of METTL14 was up to −1.052‐fold (p = 7.32×10−9) (Figure 2A) and −1.059‐fold (p = 4.86×10−4) (Figure 2B) in HCC patients, respectively. Here, METTL14 is linked to hepatocellular carcinoma.